Tiragolumab

Specification

• Cat#: THA-0342
• Product Name: Tiragolumab
• Description: Tiragolumab is an immune checkpoint inhibitor binding to T-cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab, alone or in combination with the PD-L1 inhibitor Atezolizumab, may be effective against multiple solid malignancies-most notably non-small cell lung cancer (NSCLC).
• Molecular Weight: 50/24 kDa
• Source: CHO stable cell line
• Purity: 99.04% by SEC-HPLC
• Storage: Store at -80 centigrade for 2 years. Aliquots should be stored at the same temperature after first use to avoid multiple freeze-thaws.
• Form: Liquid
• Concentration: 9.94 mg/mL
• Endotoxin Level: < 0.1 EU/mg
• Formulation: Supplied as a 0.22 μm filtered solution in PBS, pH 7.4.

Pharmaceutical Information

• Targets: TIGIT